| 28-Aug-2008 | S | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 28, 2008, inter alia, has approved the following:
The stock split i.e. sub-division of every equity shares of face value of Rs 10/- each into 10 equity shares of face value of Re 1/- each and consequential changes in Memorandum of Articles of Associations of the Company.
SUB. :- Sub Division of equity shares of Nectar Lifesciences Limited (Scrip Code 532649)
Trading members of the Exchange are hereby informed that, Nectar Lifesciences Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
COMPANY NAME CODE
Nectar Lifesciences Limited
(532649)
RECORD DATE
20/11/2008
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TEN equity shares of Re.1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
12/11/2008 DR-155/2008- 2009
The auction in the equity shares of Nectar Lifesciences Limited in Dematerialised Securities - Rolling Settlement Segment on 12/11/2008, 14/11/2008 and 17/11/2008 will be conducted as per face value of Rs.10/- each. Trading members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be in No Delivery from 12/11/2008 (DR-155/2008-2009) to 19/11/2008 (DR-159/2008-2009).
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re.1/- paid up w.e.f. 12/11/2008.
ii. ISIN No. INE023H01019 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 12/11/2008, except for the auction transactions, which will be conducted on 12/11/2008, 14/11/2008 and 17/11/2008 respectively.
iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 04.11.2008) | 20-Nov-2008 | |
| 29-Jul-2020 | D | Dividend, AGM and Book Closures as per attached Letter | 11-Sep-2020 | |
| 27-May-2019 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2019, inter alia, have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the Company, out of profits of the Company for the financial year 2018-2019, subject to the approval of the members in their Annual General
Meeting. | 19-Sep-2019 | |
| 28-May-2018 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2018, inter alia, has recommended the Final Dividend of Re. 0.05/- per equity share (5% on the face value of Re. 1/- per equity share) for the financial year 2017-18, subject to the approval of Members at their Annual General Meeting. | 19-Sep-2018 | |
| 27-Jun-2017 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 27, 2017, inter alia, have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the company, out of profits of the company for the financial year 2016-2017, subject to the approval of the members in their Annual General Meeting. | 20-Sep-2017 | |
| 30-May-2016 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016 have recommended the 10% Final Dividend i.e. Re. 0.10/- per equity share to the members of the Company, out of profits of the Company for the financial year 2015-2016, subject to the approval of the members in their Annual General Meeting. | 22-Sep-2016 | |
| 29-May-2015 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2015, have recommended the 10% Final Dividend i.e. Re. 0.10/- per equity share to the members of the Company, out of profits of the company for the financial year 2014-2015, subject to the approval of the members in their Annual General Meeting.
Nectar Lifesciences Ltd has informed BSE that the members in their Annual General Meeting held on September 30, 2015 have declared the Final Dividend of Re. 0.10/- per equity share (10% on the face value of Re. 1/- per equity share) for the financial year 2014-15.
The Dividend will be paid latest by October 28, 2015.
(As per BSE Announcement dated on 01.10.2015) | 22-Sep-2015 | |
| 28-May-2014 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2014, inter alia, have recommended the 10% Final Dividend i.e. Re. 0.10/- per equity share to the members of the Company, out of profits of the Company for the financial year 2013-2014, subject to the approval of the members in their Annual General Meeting. | 21-Aug-2014 | |
| 15-May-2013 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 15, 2013, inter alia, have recommended the 10% Final Dividend i.e. Re 0.10/- per equity share to the members of the Company, out of profits of the Company for the financial year 2012-13, subject to the approval of the members in their Annual Genera! meeting. | 19-Sep-2013 | |
| 09-Aug-2012 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2012, inter alia, have decided and approved the following :
1. The Recommendation of 10% Final Dividend i.e. Re 0.10/- per equity share to the members' of the Company, out of profits of the Company for the Financial year 2011-12. | 20-Sep-2012 | |
| 12-Aug-2011 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2011, inter alia, has recommended 10% Final Dividend i.e. Re. 0.10/- per equity share to the members of the Company, out of profits of the Company for the financial year 2010-11. | 21-Sep-2011 | |
| 15-Jan-2010 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 15, 2010, inter alia, have declared the interim dividend of Re. 0.25/- per equity share (25% on the face value of Re. 1/- per equity share) out of profits of the Company for the financial year 2009-10. | 21-Jan-2010 | |
| 30-Jun-2009 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2009, inter alia, has recommended the Final Dividend of Re 0.10/- per equity share (10% on the face value of Re 1/- per equity share) to the Members of the Company, out of profits of the Company for the financial year 2008-09.
| 03-Sep-2009 | |
| 20-Jun-2008 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 20, 2008, inter alia, have recommended the Final Dividend of RS 4/- per equity share (40% on the face value of Rs 10/- per equity share) to the Members of the Company, out of profits of the Company for the financial year 2007-08. | 18-Sep-2008 | |
| 28-Apr-2007 | D | Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2007, inter alia, has recommended a Final Dividend @ 20% to the Members. | 18-Sep-2007 | |
| 16-Jan-2006 | D | 10% Interim Dividend | 01-Feb-2006 | |
| 14-Aug-2024 | BC | Please find attached herewith the financial results for the quarter ended on June 30, 2024 | 31-May-2025 | |
| 04-Nov-2024 | BC | NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Financial Results for the quarter | 14-Nov-2024 | |
| 21-Nov-2024 | BC | Isengard Direct Pe LLC | 14-Nov-2024 | |
| 21-Nov-2024 | BC | Vedanta Opportunities Fund LP | 14-Nov-2024 | |
| 21-Nov-2024 | BC | Ingain Traders LLC & PACs | 14-Nov-2024 | |